Profile for Australia Patent: 2018282272
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2018282272
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,716,753 | May 28, 2030 | Astrazeneca | BEVESPI AEROSPHERE | formoterol fumarate; glycopyrrolate |
| 10,716,753 | May 28, 2030 | Astrazeneca Ab | BREZTRI AEROSPHERE | budesonide; formoterol fumarate; glycopyrrolate |
| 10,716,753 | May 28, 2030 | Astrazeneca | SYMBICORT AEROSPHERE | budesonide; formoterol fumarate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
